| Validation of a simplified medication adherence questionnaire in a large cohort of HIV-infected patients: the GEEMA Study H Knobel, J Alonso, JL Casado, J Collazos, J González, I Ruiz, ... Aids 16 (4), 605-613, 2002 | 674 | 2002 |
| Impact of adherence and highly active antiretroviral therapy on survival in HIV-infected patients PG de Olalla, H Knobel, A Carmona, A Guelar, JL López-Colomés, ... JAIDS Journal of Acquired Immune Deficiency Syndromes 30 (1), 105-110, 2002 | 608 | 2002 |
| Major clinical outcomes in antiretroviral therapy (ART)–naive participants and in those not receiving ART at baseline in the SMART study Strategies for Management of Antiretroviral Therapy (SMART) Study Group The Journal of infectious diseases 197 (8), 1133-1144, 2008 | 580 | 2008 |
| Dolutegravir plus lamivudine versus dolutegravir plus tenofovir disoproxil fumarate and emtricitabine in antiretroviral-naive adults with HIV-1 infection (GEMINI-1 and GEMINI-2 … P Cahn, JS Madero, JR Arribas, A Antinori, R Ortiz, AE Clarke, CC Hung, ... The Lancet 393 (10167), 143-155, 2019 | 417 | 2019 |
| Substitution of nevirapine, efavirenz, or abacavir for protease inhibitors in patients with human immunodeficiency virus infection E Martínez, JA Arnaiz, D Podzamczer, D Dalmau, E Ribera, P Domingo, ... New England Journal of Medicine 349 (11), 1036-1046, 2003 | 391 | 2003 |
| British HIV Association (BHIVA) guidelines for the treatment of HIV-infected adults with antiretroviral therapy (2006). B Gazzard HIV medicine 7 (8), 2006 | 370* | 2006 |
| Characteristics and predictors of death among 4035 consecutively hospitalized patients with COVID-19 in Spain J Berenguer, P Ryan, J Rodriguez-Bano, I Jarrín, J Carratala, J Pachon, ... Clinical Microbiology and Infection 26 (11), 1525-1536, 2020 | 368 | 2020 |
| Metabolic syndrome among HIV-infected patients: prevalence, characteristics, and related factors C Jericó, H Knobel, M Montero, J Ordoñez-Llanos, A Guelar, JL Gimeno, ... Diabetes care 28 (1), 132-137, 2005 | 295 | 2005 |
| Inferior Clinical Outcome of the CD4+ Cell Count–Guided Antiretroviral Treatment Interruption Strategy in the SMART Study: Role of CD4+ Cell Counts and HIV … Strategies for Management of Antiretroviral Therapy (SMART) Study Group The Journal of infectious diseases 197 (8), 1145-1155, 2008 | 259 | 2008 |
| Trough colistin plasma level is an independent risk factor for nephrotoxicity: a prospective observational cohort study L Sorlí, S Luque, S Grau, N Berenguer, C Segura, MM Montero, ... BMC infectious diseases 13, 1-9, 2013 | 250 | 2013 |
| Substitution of raltegravir for ritonavir-boosted protease inhibitors in HIV-infected patients: the SPIRAL study E Martinez, M Larrousse, JM Llibre, F Gutierrez, M Saumoy, A Antela, ... Aids 24 (11), 1697-1707, 2010 | 245 | 2010 |
| Osteopenia in HIV-infected patients: is it the disease or is it the treatment? H Knobel, A Guelar, G Vallecillo, X Nogués, A Díez Aids 15 (6), 807-808, 2001 | 233 | 2001 |
| Eosinophil count and neutrophil-lymphocyte count ratio as prognostic markers in patients with bacteremia: a retrospective cohort study R Terradas, S Grau, J Blanch, M Riu, P Saballs, X Castells, JP Horcajada, ... Public Library of Science 7 (8), e42860, 2012 | 232 | 2012 |
| Dual treatment with lopinavir–ritonavir plus lamivudine versus triple treatment with lopinavir–ritonavir plus lamivudine or emtricitabine and a second nucleos (t) ide reverse … JR Arribas, PM Girard, R Landman, J Pich, J Mallolas, ... The Lancet Infectious Diseases 15 (7), 785-792, 2015 | 194 | 2015 |
| Impact of syphilis infection on HIV viral load and CD4 cell counts in HIV-infected patients R Palacios, F Jiménez-Oñate, M Aguilar, MJ Galindo, P Rivas, A Ocampo, ... JAIDS Journal of Acquired Immune Deficiency Syndromes 44 (3), 356-359, 2007 | 184 | 2007 |
| Risk for opportunistic disease and death after reinitiating continuous antiretroviral therapy in patients with HIV previously receiving episodic therapy: a randomized trial SMART Study Group* Annals of internal medicine 149 (5), 289-299, 2008 | 165 | 2008 |
| HIV infection is strongly associated with hip fracture risk, independently of age, gender, and comorbidities: a population‐based cohort study R Güerri‐Fernandez, P Vestergaard, C Carbonell, H Knobel, FF Avilés, ... Journal of Bone and Mineral Research 28 (6), 1259-1263, 2013 | 152 | 2013 |
| Lopinavir-ritonavir monotherapy versus lopinavir-ritonavir and 2 nucleosides for maintenance therapy of HIV: 96-week analysis JR Arribas, R Delgado, A Arranz, R Muñoz, J Portilla, J Pasquau, ... JAIDS Journal of Acquired Immune Deficiency Syndromes 51 (2), 147-152, 2009 | 144 | 2009 |
| Dual therapy with darunavir and ritonavir plus lamivudine vs triple therapy with darunavir and ritonavir plus tenofovir disoproxil fumarate and emtricitabine or abacavir and … F Pulido, E Ribera, M Lagarde, I Pérez-Valero, R Palacios, JA Iribarren, ... Clinical Infectious Diseases 65 (12), 2112-2118, 2017 | 130* | 2017 |
| Adherence and effectiveness of highly active antiretroviral therapy H Knobel, A Carmona, S Grau, J Pedro-Botet, A Díez Archives of Internal Medicine 158 (17), 1953-1953, 1998 | 128 | 1998 |
